Complications in hepatic vein catheterisation and transjugular liver biopsy.

IF 1 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Danish medical journal Pub Date : 2023-12-18

Nanna Hansen, Annette Dam Fialla

{"title":"Complications in hepatic vein catheterisation and transjugular liver biopsy.","authors":"Nanna Hansen, Annette Dam Fialla","doi":"","DOIUrl":null,"url":null,"abstract":"Introduction: Portal pressure predicts the occurrence of decompensations in cirrhosis. Portal pressure is primarily measured via hepatic vein catheterisation (HVC), to which a transjugular liver biopsy (TJLB) may be added. Indications for HVC are mainly therapy control and prognosis. TJLB is performed when a percutaneous liver biopsy is contraindicated or for other diagnostic reasons. Both procedures have reported low complication rates. The aim of this study was to identify indications and 30-day postprocedural complications.Methods: Based on procedure codes, a list was generated in the report database compromising procedures from 1 January 2018 to 31 January 2022. Procedures were identified in electronic charts (Cosmic Arkiv). A total of 209 patients undergoing 277 procedures were included. Information regarding indications, complications, age, sex, diagnosis, comorbidity and blood tests was also analysed.Results: The more frequently reported indications for HVC were control of betablockers and diagnosis. Indications for TJLB were diagnostic and research purposes. Complications after HVC included pain and transient supraventricular arrythmias. Four major complications after TJLB were found, which led to admission due to various causes of bleeding.Conclusion: HVC and TJLB are safe procedures. The complication rate for HVC and TJLB was 3.3% and 6.8%, respectively. Complications were minor; only four major complications after TJLB were found - none of which were mortal.Funding: None.Trial registration: Not relevant.","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":"71 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Portal pressure predicts the occurrence of decompensations in cirrhosis. Portal pressure is primarily measured via hepatic vein catheterisation (HVC), to which a transjugular liver biopsy (TJLB) may be added. Indications for HVC are mainly therapy control and prognosis. TJLB is performed when a percutaneous liver biopsy is contraindicated or for other diagnostic reasons. Both procedures have reported low complication rates. The aim of this study was to identify indications and 30-day postprocedural complications.

Methods: Based on procedure codes, a list was generated in the report database compromising procedures from 1 January 2018 to 31 January 2022. Procedures were identified in electronic charts (Cosmic Arkiv). A total of 209 patients undergoing 277 procedures were included. Information regarding indications, complications, age, sex, diagnosis, comorbidity and blood tests was also analysed.

Results: The more frequently reported indications for HVC were control of betablockers and diagnosis. Indications for TJLB were diagnostic and research purposes. Complications after HVC included pain and transient supraventricular arrythmias. Four major complications after TJLB were found, which led to admission due to various causes of bleeding.

Conclusion: HVC and TJLB are safe procedures. The complication rate for HVC and TJLB was 3.3% and 6.8%, respectively. Complications were minor; only four major complications after TJLB were found - none of which were mortal.

Funding: None.

Trial registration: Not relevant.

本刊更多论文

肝静脉导管插入术和经颈静脉肝活检术的并发症。

简介门静脉压力可预测肝硬化失代偿的发生。门静脉压力主要通过肝静脉导管插入术（HVC）进行测量，也可增加经颈静脉肝活检术（TJLB）。肝静脉导管术的适应症主要是治疗控制和预后。经颈静脉肝穿刺活检是在经皮肝穿刺活检有禁忌或出于其他诊断原因的情况下进行的。据报道，这两种手术的并发症发生率都很低。本研究旨在确定适应症和术后 30 天的并发症：根据手术代码，在报告数据库中生成了一份清单，涉及 2018 年 1 月 1 日至 2022 年 1 月 31 日期间的手术。手术在电子病历（Cosmic Arkiv）中得到确认。共纳入了 209 名接受 277 项手术的患者。同时还分析了有关适应症、并发症、年龄、性别、诊断、合并症和血液检查的信息：结果：报告较多的 HVC 适应症是控制受体阻滞剂和诊断。TJLB的适应症是诊断和研究目的。HVC 术后并发症包括疼痛和一过性室上性心律失常。TJLB术后发现了四种主要并发症，这些并发症因各种出血原因导致入院：结论：HVC 和 TJLB 是安全的手术。HVC和TJLB的并发症发生率分别为3.3%和6.8%。并发症均为轻微并发症；TJLB术后仅发现4例主要并发症，均不致命：无：试验注册：不相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Danish medical journal MEDICINE, GENERAL & INTERNAL-

CiteScore

2.30

自引率

6.20%

发文量

审稿时长

3-8 weeks

期刊介绍： The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content. DMJ will publish the following articles: • Original articles • Protocol articles from large randomized clinical trials • Systematic reviews and meta-analyses • PhD theses from Danish faculties of health sciences • DMSc theses from Danish faculties of health sciences.